Kim, Hyeree
(Department of Dermatology, The Catholic University of Korea, Incheon St. Mary's Hospital, Incheon, Korea.)
,
Park, Chun Wook
(Department of Dermatology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea.)
,
Cho, Sang Hyun
(Department of Dermatology, The Catholic University of Korea, Incheon St. Mary's Hospital, Incheon, Korea.)
BackgroundAtopic dermatitis (AD) is a chronic or chronically relapsing, eczematous, severely pruritic inflammatory skin disorder. Korean red ginseng (KRG) has been shown previously to exhibit diverse biological effects including anti-inflammatory and antipruritic effects in a murine model.ObjectiveW...
BackgroundAtopic dermatitis (AD) is a chronic or chronically relapsing, eczematous, severely pruritic inflammatory skin disorder. Korean red ginseng (KRG) has been shown previously to exhibit diverse biological effects including anti-inflammatory and antipruritic effects in a murine model.ObjectiveWe aimed to investigate the beneficial effects of KRG on AD patients, to determine whether there was improvement in disease severity, skin barrier function, pruritus and sleep disturbance relief.MethodsAn open, noncomparative clinical study that utilized KRG tablets (500 mg/tablet) was conducted. This study included 41 patients with mild to moderate AD diagnosed by the Korean atopic dermatitis guidelines. Three visits to the hospital at days 1, 28±7, and 56±7 for evaluation were made. The effects of KRG were assessed by measuring eczema area and severity index (EASI) score, transepidermal water loss (TEWL), the visual analogue scale (VAS), total amount of topical agents used in recent 8 weeks and investigator global assessment (IGA).ResultsPatients taking KRG tablets showed significant decreases in EASI score and TEWL, and the VAS of pruritus and sleep disturbance were significantly reduced. The amount of topical agents used was reduced but not by a statistically significant amount. IGA at the third visit showed improvement of AD compared to the second visit, but the difference was not statistically significant.ConclusionKRG can be safely used as a health food to achieve clinical improvement of AD as well as improving overall quality of life, and has potential for further development.
BackgroundAtopic dermatitis (AD) is a chronic or chronically relapsing, eczematous, severely pruritic inflammatory skin disorder. Korean red ginseng (KRG) has been shown previously to exhibit diverse biological effects including anti-inflammatory and antipruritic effects in a murine model.ObjectiveWe aimed to investigate the beneficial effects of KRG on AD patients, to determine whether there was improvement in disease severity, skin barrier function, pruritus and sleep disturbance relief.MethodsAn open, noncomparative clinical study that utilized KRG tablets (500 mg/tablet) was conducted. This study included 41 patients with mild to moderate AD diagnosed by the Korean atopic dermatitis guidelines. Three visits to the hospital at days 1, 28±7, and 56±7 for evaluation were made. The effects of KRG were assessed by measuring eczema area and severity index (EASI) score, transepidermal water loss (TEWL), the visual analogue scale (VAS), total amount of topical agents used in recent 8 weeks and investigator global assessment (IGA).ResultsPatients taking KRG tablets showed significant decreases in EASI score and TEWL, and the VAS of pruritus and sleep disturbance were significantly reduced. The amount of topical agents used was reduced but not by a statistically significant amount. IGA at the third visit showed improvement of AD compared to the second visit, but the difference was not statistically significant.ConclusionKRG can be safely used as a health food to achieve clinical improvement of AD as well as improving overall quality of life, and has potential for further development.
2 Homey B Steinhoff M Ruzicka T Leung DY Cytokines and chemokines orchestrate atopic skin inflammation J Allergy Clin Immunol 2006 118 178 189 16815153
3 Szegedi A Baráth S Nagy G Szodoray P Gál M Sipka S Regulatory T cells in atopic dermatitis: epidermal dendritic cell clusters may contribute to their local expansion Br J Dermatol 2009 160 984 993 19222459
4 Hinz D Bauer M Röder S Olek S Huehn J Sack U Cord blood Tregs with stable FOXP3 expression are influenced by prenatal environment and associated with atopic dermatitis at the age of one year Allergy 2012 67 380 389 22187950
5 Shibata S Fujita M Itokawa H Tanaka O Ishii T Studies on the constituents of Japanese and Chinese crude drugs. XI. Panaxadiol, a sapogenin of ginseng roots Chem Pharm Bull (Tokyo) 1963 11 759 761 14068710
6 Bae EA Trinh HT Yoon HK Kim DH Compound K, a metabolite of ginsenoside Rb1, inhibits passive cutaneous anaphylaxis reaction in mice J Ginseng Res 2009 33 93 98
7 Ro JY Ahn YS Kim KH Inhibitory effect of ginsenoside on the mediator release in the guinea pig lung mast cells activated by specific antigen-antibody reactions Int J Immunopharmacol 1998 20 625 641 9848395
8 Lee JH Cho SH Korean red ginseng extract ameliorates skin lesions in NC/Nga mice: an atopic dermatitis model J Ethnopharmacol 2011 133 810 817 21094681
9 Cho E Cho SH Effects of Korean red ginseng extract on the prevention of atopic dermatitis and its mechanism on early lesions in a murine model J Ethnopharmacol 2013 145 294 302 23149290
14 Lee HJ Cho SH Therapeutic effects of Korean red ginseng extract in a murine model of atopic dermatitis: anti-pruritic and anti-inflammatory mechanism J Korean Med Sci 2017 32 679 687 28244297
AI-Helper
※ AI-Helper는 부적절한 답변을 할 수 있습니다.